Revance Therapeutics Inc. buy Maxi_Scalibusa
Start price
17.02.19
/
50%
€15.82
Target price
03.04.19
€27.06
Performance (%)
-14.60%
End price
03.04.19
€13.51
Summary
This prediction ended on 03.04.19 with a price of €13.51. The price of Revance Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -14.60%. Maxi_Scalibusa has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Revance Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 0.388% | 0.145% | 10.959% | 58.440% |
| iShares Nasdaq 100 | 1.307% | -2.548% | -0.608% | 84.240% |
| iShares Nikkei 225® | -0.463% | 6.891% | 26.748% | 63.400% |
| iShares S&P 500 | 1.314% | -1.163% | -0.036% | 58.216% |
Comments by Maxi_Scalibusa for this prediction
In the thread Revance Therapeutics Inc. diskutieren
Revance Therapeutics
(Stop Loss Kurs erreicht)


